Blink Health, which makes an app and online tool for helping consumers find low prices on medications, is suing competitor Hippo Technologies for up to $250 million, alleging a “copycat” scheme. The lawsuit claims that Hippo, which was founded by former Blink employees, obtained trade secrets, participated in unfair competition, took part in tortious interference with contract and business retaliation.
from MobiHealthNews http://ift.tt/2pfMScK
March 16, 2018
Rose
MobiHealthNews
No comments
Related Posts:
Biogen launches new app, Aby, for patients with MSBiogen has just launched a new app, called Aby, aimed at giving people living with multiple sclerosis (MS) accurate and reliable information about the condition and support. from MobiHealthNews https://ift.tt/2sUqzMv … Read More
WebMD acquires Jobson to bolster content for pharmacists, eye health practicionersInternet Brands subsidiary WebMD, which also oversees the Medscape brand of physician-facing mobile and web-based educational content, has acquired Jobson Healthcare Information, another healthcare content group, for an … Read More
Survey: Hospitals' adoption of mobile strategies hits a snagWhen healthcare communications firm Spok first began investigating the prevalence of mobile strategies in 2012, only a third of survey respondents reported that their organization had a formalized strategy in place. from Mob… Read More
CMS relents, opens up smartphone-connected CGMs for reimbursementThe Centers for Medicare and Medicaid Services will reverse a longstanding unpopular position on reimbursement for smartphone-connected continuous glucose monitors, CMS announced yesterday. from MobiHealthNews https://ift.tt… Read More
Swedish telemedicine provider Kry announces $66M Series B fundingStockholm, Sweden-based telemedicine app company Kry announced this week that it has raised $66 million (53 million euros) in Series B funding. The round was led by Index Ventures, and also included the company’s existing inv… Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment